We have analysed in vivo the 72.0 kb enhancer of the human urokinase-type plasminogen activator (uPA) gene in HepG2 cells, in which gene expression can be induced by phorbol esters. The results reveal that, within the regulatory region, the enhancer, the silencer and the minimal promoter become hypersensitive to deoxyribonuclease I (DNase I) upon induction of transcription. The hypersensitivity of the enhancer can be reversed after removal of the inducer. In vivo footprinting analysis indicates that all the cis-acting elements of the enhancer, previously identi®ed in vitro, are occupied in vivo upon 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulation of HepG2 cells. Micrococcal nuclease (MNase) cleavage of this region fails to reveal discrete nucleosomal boundaries in vivo in close proximity of the enhancer, either before or after stimulation. Furthermore, this region does not lose its nucleosomal con®guration after TPA induction of transcription. An approximately 600 bp long region around the enhancer becomes more, but not fully, accessible to restriction endonucleases upon stimulation. A time-course experiment shows that this accessibility reaches a plateau after a 1 h TPA treatment suggesting the persistent presence of nucleosomes. These results indicate that TPA induces the binding of transcription factors to the uPA enhancer without chromatin remodelling of this region.
Introduction
uPA is a serine protease, which triggers a proteolytic cascade leading to the degradation of the extra cellular matrix and cell motility (Besser et al., 1996) . In addition, uPA is involved also in non-proteolytic signalling events leading to adhesion and chemotaxis (Besser et al., 1996; Blasi, 1997) . uPA is also a major component in tumour invasion and metastasis and its high levels in mammary tumours are predictive of poor prognosis (Danù et al., 1994; JaÈ nicke et al., 1990) .
Transcription of the human uPA gene is promoted by a TATA box-containing minimal promoter, rich in Sp1 sites, and is strongly modulated by an inducible enhancer, located at 72.0 kb (Verde et al., 1988) . Enhancer activity requires the cooperation of an upstream combined PEA3/AP-1 A and a downstream AP-1 B site (Berthelsen et al., 1996; De Cesare et al., 1995; Nerlov et al., 1992) . The AP-1 sites are separated by a 74 bp`cooperation mediator' (COM) region, which contains the binding sites for several proteins, named urokinase enhancer factors (UEF; Berthelsen et al., 1996; De Cesare et al., 1996; Nerlov et al., 1992) . In HeLa cells, the NF-kB site at 71865, downstream of AP-1 B and in A549 cells the site at 71592 have also been reported to play a role in phorbol esters induction of uPA gene expression (Guerrini et al., 1996; Novak et al., 1991) . Finally, a negative regulatory element, which modulates the enhancer activity, has been identi®ed *600 bp upstream from the start of transcription (Cannio et al., 1991) .
To date, little is known on the mechanisms underlying the transcriptional activation of the human uPA gene in vivo. Two previous reports correlate the presence of DNase I hypersensitive sites in the porcine uPA promoter with its inducibility by cAMP in LLC-PK1 cells (Lee et al., 1994) and by TPA and FGF-2 in NIH3T3 cells (D'Orazio et al., 1997) , but none deals with the dynamics of the nucleosomal structure of this region. In this work we report that: three sites of the human uPA regulatory region become hypersensitive to DNase I, one of them corresponding to the enhancer, upon stimulation with TPA, with a time-course correlating directly with that of the increase in uPA mRNA level. The enhancer region shows no evidence for a discrete positioning of nucleosomes or loss of nucleosomal structure following TPA stimulation. In vivo genomic footprinting shows stimulation-dependent occupancy of all the cis-acting elements of the enhancer, previously identi®ed in vitro. Moreover, part of the regulatory region surrounding the enhancer, and broader than the enhancer itself, becomes more, but not fully, accessible to restriction enzymes.
We conclude that in non-stimulated cells the enhancer region is packed in non-uniquely positioned nucleosomes, which are maintained after stimulation with TPA, indicating that the binding of transcription factors does not require the remodelling of the enhancer.
Results
TPA induces uPA mRNA transcription and leads to the formation of DNase I hypersensitive sites in the uPA gene regulatory region In vivo, under non-pathological conditions, the expression of the uPA gene is limited to few migrating cells and to epithelial kidney cells; however, tissue culture cells may express the gene either constitutively or upon stimulation. A time-course experiment with phorbol esters in HepG2 cells showed that uPA mRNA is visible after 1 h, reaches its maximum at 3 h ( Figure 1a) and starts declining at 9 h (data not shown and see Nerlov et al., 1992) . A similar timecourse experiment shows that urokinase is detectable by immuno¯uorescence after 1 h stimulation and remains constant up to 3 h in 590% of HepG2 cells (data not shown). These results indicate that tetradecanoyl phorbol acetate induces uPA expression in the vast majority of cells and not in a minority of the cell population.
To understand the mechanisms by which TPA induces uPA gene expression, we performed in vivo DNase I hypersensitivity analysis of the uPA gene regulatory region. A schematic map of the region of the human uPA gene locus analysed is given in Figure  1b . It includes the 72.0 kb enhancer (E), the 7600 bp silencer (S) and the minimal promoter (MP). The locations of the probes and restriction enzymes used are indicated. All probes were used for indirect endlabelling analysis of Southern blots. Probe p2, used for detection of DNase I hypersensitive sites throughout the regulatory region goes from +488 to +826 and recognizes an 8.1 kb XmnI restriction fragment from nucleotide +891 to 77210. This fragment contains the ®rst two exons and introns of the uPA gene, *2.4 kb of sequenced plus *4.8 kb of unsequenced 5'-¯anking region. Probe p5 (from 7812 to 7312) was used to uniquely detect the DNase I hypersensitive site on the enhancer. Moreover, probe p5, together with probe p14 (from 71692 to 71991), were used for restriction enzyme accessibility studies. They detect a TaqI restriction fragment from 72441 to 7191. Probe p14 also recognizes an AspI restriction fragment from 71692 to 72280. The probes were tested on Southern blots of genomic DNA, restricted with the appropriate enzymes, to ensure the detection of single bands of the expected size (data not shown).
The alterations in chromatin structure of the uPA promoter are rapid. A 3 h TPA-treatment of HepG2 cells, which allows the detection of uPA mRNA ( Figure 1a) induces DNase I hypersensitivity in correspondence of the functional elements of the regulatory region of the uPA gene (Figure 2 ). Isolated nuclei from untreated and TPA-treated HepG2 cells were digested with DNase I and the genomic DNA analysed on Southern blots by indirect end-labelling using probe p2, following restriction with XmnI. Nonstimulated HepG2 cells showed a band indicating hypersensitivity around 73.5 kb (Figure 2 , lanes 2 and 3). In addition, stimulated cells showed bands of hypersensitivity at about 74500, 71950, 7600 and 723 bp from the start of transcription (Figure 2 , lanes 5 and 6). The region around 71950 bp corresponds to the uPA enhancer (E), that around 7600 bp to the silencer (S), while the 723 bp site corresponds to the start of transcription (Figure 2 ). Thus, in TPA, stimulated HepG2 cells, discrete DNase I hypersensitive sites map at functional elements of the uPA promoter. In the following, we have focused our attention on the hypersensitive site mapping at the uPA enhancer.
Time-course of appearance and reversibility of the DNase I hypersensitive site on the enhancer
We have analysed the time-course of the onset of the hypersensitivity on the enhancer region and its disappearance after TPA removal. We employed indirect end-labelling of TaqI-restricted genomic DNA with probe p5 to uniquely detect the enhancer. As shown in Figure 3 (lanes 5 ± 8), enhancer hypersensitivity already appeared after a 1 h stimulation and became prominent at 2 and 3 h (Figure 3 , lanes 9 ± 12 and 13 ± 16, respectively). This result well correlates with the time-course of uPA mRNA stimulation in these cells (Nerlov et al., 1992) , where the maximum level of uPA mRNA induction by TPA in HepG2 cells is reached Figure 1 Induction of uPA expression by TPA treatment of HepG2 cells and scheme of the strategy and probes used in this study. (a) Total RNA (50 mg) from untreated and TPA-treated (100 ng/ml TPA for 5 h) HepG2 cells (50 mg) was run on a 1% (w/v) formaldehyde/agarose gel, blotted and hybridized with a human uPA cDNA probe. The blot was stripped and hybridized to a GAPDH probe for normalization. (b) Schematic representation of the human uPA regulatory region. Restriction enzymes and their sites relative to the start of transcription (arrow at +1) are indicated. White boxes represent, from the left: E: enhancer; S: silencer; MP: minimal promoter. Boxes with roman numerals to the right of the start of transcription represent the exons (black boxes: untranslated regions). Hatched boxes: probes used in this study; probe names and sizes are to the left and below the boxes, respectively after 3 h. DNase I hypersensitivity of the enhancer disappeared upon removal of the inducer. Following a 3 h treatment with TPA, HepG2 cells were washed for 3 h with fresh medium; nuclei were then isolated and processed as above. As shown in lanes 17 ± 19 of Figure  3 , the prominent band corresponding to the enhancer was no longer present. Since the time span needed for the onset and disappearance of the DNase I hypersensitivity of the enhancer was rather short, it is unlikely that these processes require DNA replication. Our data also suggest that the presence of the inducer is required for the maintenance of DNase I hypersensitivity on the enhancer.
Since hypersensitive sites are indicative of a discontinuity in the chromatin ®bre and may be a consequence of nucleosomal loss and binding of speci®c proteins (Lis and Wu, 1995) , we investigated the latter event in vivo in our system.
Transcription factors binding to the uPA enhancer in vivo
In an attempt to relate the observed DNase I hypersensitivity of the enhancer to the occupancy of transcription factors in vivo and to possible changes in the chromatin structure of this region, we performed in vivo footprinting experiments on untreated or TPAtreated HepG2 cells or on nuclei isolated from the above cells. The procedure was performed with LTS LM-PCR (see Materials and methods) using DMS-or DNase I-cleaved genomic DNA. DMS in vivo footprinting reproducibly showed two hyperreactive bands in the DNA from TPA-treated cells in the region of AP-1 B at the 3'-end of the enhancer (Figure 4) . In other areas of the enhancer, we observe more subtle dierences in the pattern between untreated and treated cells, in particular in the uCOM and dCOM regions, which appear partially protected, and in the PEA3/AP1 A site, which is also partially aected. In addition, also the NF-kB region, downstream of the AP-1 B site, was modi®ed upon treatment. These results were con®rmed also by the analysis of the opposite strand (data not shown) and are compatible with occupancy of the enhancer by transcription factors after TPA stimulation.
When in vitro footprinting was performed with DNase I the pattern again changed upon TPA- Figure 2 DNase I hypersensitive sites in the human uPA promoter. Nuclei from untreated and TPA-treated HepG2 cells were isolated and digested with DNase I (0 U/ml, lanes 1 and 4; 3 U/ml lanes 2 and 5; 7.5 U/ml lanes 3 and 6), as described in Materials and methods. Puri®ed DNA (40 mg) was restricted with XmnI, fractionated on a 1% (w/v) agarose gel, transferred to a nylon membrane, probed with p2 ( Figure 1b ) and autoradiographed. The distance of the DNase I hypersensitive cleavage sites with respect to the start of transcription are indicated on the right together with the main features of the uPA promoter. Note that the sites on the enhancer, silencer, and minimal promoter are visible following TPA induction of transcription, together with two sites upstream of the regulatory region of the human uPA gene (74500 and 73500) Figure 3 Time course analysis of the formation and reversal of the DNase I hypersensitive site on the enhancer. HepG2 cells were treated with 100 ng/ml TPA for the times indicated or treated with TPA for 3 h, washed and incubated for another 3 h with fresh medium. Nuclei were isolated and subjected to digestion with dierent concentrations of DNase I: 0 U/ml (lanes 1, 5, 9, 13 and 17); 3 U/ml (lanes 2, 6, 10, 14 and 18); 7.5 U/ml (lanes 3, 7, 11, 15 and 19); 12 U/ml (lanes 4, 8, 12 and 16) . Subsequently the DNA was puri®ed, cleaved with TaqI, separated on a 1% (w/v) agarose gel, blotted and subjected to indirect end labelling analysis with p5 (see Figure 1b ). The position of the hypersensitive site (HS) on the enhancer is indicated on the right. The presence of the inducer is required for the maintenance of the hypersensitivity of the enhancer treatment and con®rmed the presence of bound transcription factors to the uPA enhancer following induction of transcription ( Figure 5 ). In this case, the sites that bind transactivating factors (PEA3, AP-1 A and AP-1 B ) were fully protected. Moreover, the uCOM, dCOM and NF-kB regions show the appearance of new bands in the TPA-treated sample and a dierential sensitivity of some of the bands already present, both of which are compatible with occupancy of these regions. DNase I cleavages observed in the naked DNA sample and common to the TPA-treated or untreated samples have not been considered in the above discussion.
The pattern of DNase I footprinting in untreated cells (lane 3 in Figure 5 ) did not show enhanced cleavage at *10 bp distance in the enhancer or overlapping patterns of such a cleavage. This pattern would have indicated the presence of a uniquely positioned nucleosome, in the ®rst case, or of overlapping nucleosome positioning in the second. These data were con®rmed by analysis of the opposite strand (data not shown). Thus our data suggest that nucleosomes are not uniquely positioned on the uPA enhancer of untreated cells. Overall, the results of in vivo footprinting with DMS and DNase I show that transcription factors are bound to the uPA enhancer following TPA stimulation of the cells (Table 1) .
In vivo MNase analysis of the chromatin structure on the uPA enhancer To gain further insight into the chromatin structure of the enhancer during TPA stimulation, we expanded our LM ± PCR analysis to MNase-treated nuclei from unstimulated and stimulated HepG2 cells. The results obtained, shown in Figure 6 , suggest that the analysed sequence can be approximately divided into two regions: one between bp 71976 and 71858, spanning the enhancer, and the other from bp 71858 to 71783. In the latter, the pattern of naked DNA shows the presence of preferential MNase cleavage sites, some of which correspond to AT-rich regions ( Figure 6 ; lane 2, Figure 4 In vivo footprinting of transcription factors bound to the uPA enhancer: DMS cleavage of genomic DNA. Unstimulated and TPA-stimulated HepG2 cells were treated with DMS and LTS LM ± PCR was performed as described in Materials and methods. Naked DNA was treated with DMS as described to yield the`G' lane (lane 1). The numbering to the left indicates the relevant positions on the sequence of the cis-acting elements of the enhancer indicated in the scheme to the right, as previously identi®ed in vitro. Empty circles indicate protected G residues; black circles indicate hyperreactive G residues. Note that all the cis-acting elements of the enhancer yield a footprint in vivo 1 2 3 4 Figure 5 In vivo footprinting of the uPA enhancer region: DNase I cleavage of genomic DNA. Nuclei from untreated and TPAtreated HepG2 cells were isolated and digested with 0.5 U/ml DNase I at 378C for 10 min (lanes 3 and 4), while naked DNA was treated with 0.1 U/ml of DNase I at 378C for 2 min (lane 2). The G pattern (lane 1) is as in Figure 4 . Puri®ed DNA was processed for LTS LM ± PCR as described (see Materials and methods). The numbering to the left and the scheme to the right are as in Figure 4 . A clear change in the pattern between unstimulated and stimulated cells can be observed, as the result of binding of transcription factors e.g. between bp 71807 and 71795 and between bp 71790 and 1783). In untreated cells, some of the preferential sites corresponding to those observed in naked DNA are more prominently cleaved ( Figure 6 , compare lanes 2 and 3 at bp 71832 and 71804), some are present only in untreated cells (i.e. at bp 71825) and some are protected from the activity of the enzyme (e.g.: the sites centred around bp 71815 and 71790). In the enhancer region, the pattern observed in naked DNA and untreated cells is dierent, although a few preferential MNase cleavage sites are maintained between naked DNA and untreated cells (Figure 6 ; lanes 2 and 3 between bp 71976 and 71858). Furthermore, the region from upstream bp 71976 to the 3' end of the uCOM seems to reproduce the pattern observed at the 3' end of the enhancer with some preferential sites more prominently cleaved, but an overall protection from MNase activity ( Figure 6 , lanes 2 and 3). We also do not observe one or more bands which could be indicative of nucleosomal boundaries and, therefore, of positioned nucleosomes. Overall, these observations are compatible with the nucleosomal organization of this region in non-stimulated cells, although no unique nucleosome positioning can be inferred. This result has been reproduced several times.
In TPA-treated cells, the pattern observed from the top of the gel to the 3' end of the enhancer region (bp 71858) reproducibly shows that MNase cleavage clearly changed and that these changes can be correlated with the presence of transcription factors bound to the enhancer (Figure 6 , see also Figures 4 and 5). We observe regions of increased sensitivity to the enzyme (Figure 6 , compare lanes 3 and 4 between the AP1 B and NF-kB sites and between the AP1 B and the dCOM region) and of full or partial protection (e.g. the PEA3/AP1 A or AP1 B sites). The region 3' of the enhancer shows a substantial dierence from unstimulated cells in the sequence comprised between 71858 and 71842 ( Figure 6 , lanes 3 and 4), while bp 71842 to 71783 the pattern closely resembles that of naked DNA and untreated cells, although it appears more accessible to MNase than the latter (Figure 4 , lanes 2, 3 and 4). We conclude that, also in the case of TPA-stimulated cells, the analysed sequence is at least partially protected by non-uniquely positioned nucleosomes.
The results were con®rmed by cleaving DNA with 1,10-phenantroline-copper (OP-Cu), a chemical agent which intercalates DNA and allows to avoid the sequence preference bias of MNase Becker, 1996, 1997 ) (data not shown). To further establish the presence of nucleosomes on the enhancer both in untreated and TPA-treated cells, we analysed by indirect end-labelling OP-Cu-treated DNA from control and TPA-treated nuclei, using a multimerized enhancer probe. The results show a typical nucleosomal ladder which is maintained also after stimulation with TPA ( Figure 7) .
Thus we conclude that non-uniquely positioned nucleosomes fold the enhancer region of the uPA gene in non-stimulated cells and that such folding is not lost upon stimulation with TPA, although the region becomes more accessible to binding by transcription factors.
Restriction enzyme accessibility of the uPA enhancer region
The failure to detect nucleosomal boundaries in close proximity of the enhancer in TPA-treated cells and the failure to detect a change in the nucleosomal DNA ladder in this region indicates that binding of the transcription factors to their cognate sequences in the enhancer may take place in the context of chromatin. Thus, we have used restriction enzymes to assess the accessibility of this region (Verdin et al., 1993) . Isolated nuclei form untreated and TPA-treated HepG2 cells were digested with eleven restriction enzymes mapping Figure 6 In vivo LTS LM ± PCR analysis of genomic DNA from MNase-digested nuclei of untreated and TPA-treated HepG2 cells does not reveal nucleosomal boundaries. Isolated nuclei from untreated and phorbol ester-treated HepG2 cells were digested with 3 U/ml MNase at 378C for 2 min (lanes 3 and 4), while naked DNA was treated with 0.1 U/ml of the enzyme at the same temperature for 2 min (lane 2). The G pattern (lane 1) was obtained as in Figure 4 . Puri®ed DNA was then processed for LTS LM ± PCR as described. Positions and enhancer elements are indicated to the left and right, respectively. Note that no clear nucleosomal boundaries can be observed in close proximity of the enhancer In vivo analysis of the enhancer of the human uPA gene I Iban Äez-Tallon et al within the enhancer and in its 5' and 3'-¯anking regions ( Figure 8a) . The region was then analysed by indirect end-labelling with probe p5 or with probe p14, following restriction of genomic DNA with TaqI and AspI, respectively (see scheme in Figure 1b) . We ®nd that nine restriction sites, from 72210 to 71663, become more susceptible to the respective restriction enzyme upon stimulation (Figure 8b ). Two further sites (BstEII and StuI), mapping at 71628 and 71429, are not aected by TPA treatment. The restriction enzymes used do not completely cleave their sites, indicating that the region may be more, but not fully, accessible to endonucleases in stimulated vs unstimulated cells. Thus, we performed the same assay on nuclei from HepG2 cells stimulated with TPA for increasing time periods using the BspHI endonuclease which maps within the enhancer (71881). TPA stimulation increases BspHI accessibility (i.e. low molecular weight band) very rapidly, reaching a maximum at 1 h treatment and remaining thereafter constant ( Figure  9 ). Quantitation of the relative intensity of the bands in the autoradiogram indicates a decrease in the TaqI band (i.e. high molecular weight) and thus these results suggest that TPA does not induce the disruption of the nucleosomal stucture of the enhancer, although the region becomes more accessible.
Discussion
Dierent physiological and pathological processes require cell motility and many of them depend on the In vivo analysis of the enhancer of the human uPA gene I Iban Äez-Tallon et al involvement of uPA. This requires a ®ne-tuning of transcriptional regulation of the uPA gene and a rapid response to dierent extracellular stimuli. Indeed, uPA transcription is stimulated by essentially all chemokines, hormones, growth and dierentiation factors (Besser et al., 1996) . The enhancer of the uPA gene is the target of this regulation, as shown at least for epidermal growth factor and TPA, (Rùrth et al., 1990) , interleukin-1 (Novak et al., 1991) , granulocyte-macrophage colony stimulating factor (Stacey et al., 1995) and processes and drugs modifying cytoskeletal organization (Lee et al., 1993) . In this paper, we have focused our attention on the eect of TPA on the in vivo structure of the enhancer. This element is located at about 2000 bp upstream of the transcription start site and contains three binding sites for transactivating factors: Ets-2 and the heterodimers c-Jun/ATF2 bind the combined PEA3/AP1 A sites, while c-Jun/c-Fos binds the AP1 B sites (Berthelsen et al., 1996; De Cesare et al., 1995; Lee et al., 1993; Rùrth et al., 1990; Verde et al., 1988) . The activity of these sites is cooperatively coordinated by a 74 bp region, COM, located between the two AP1 sites, which is required for enhancer activity, although the proteins binding to it have no transactivating activity per se (Berthelsen et al., 1996; De Cesare et al., 1996) . We have tried to integrate this information, mostly coming from in vitro or transient transfections data, with an in vivo analysis of the structure of this element, since it plays an important role in the regulation of stimulated uPA expression. Phorbol esters are known to induce DNase I hypersensitivity (Li et al., 1998; Winter et al., 1990) and the results from our experiments indicate that TPA treatment of HepG2 cells for 1 ± 3 h results in the induction of uPA production in 590% of the cell population. During the same time span, the general sensitivity to nucleases of the region surrounding and including the enhancer reaches a maximum within 1 h of treatment and remains constant thereafter (Figures 8  and 9 ). These results parallel the observations that: (1) a hypersensitive site on the enhancer can already be observed after a 1 h stimulation (Figure 3 ) and that (2) the enhancer, the silencer and the minimal promoter become hypersensitive to DNase I after a 3 h treatment (Figures 2 and 3) . Interestingly, the time-course of DNase I hypersensitivity induction (Figure 3 ) and of the increase in mRNA level (not shown, but see our previous results in Nerlov et al., 1992) correlate very well.
DNase I hypersensitivity has been shown to be due to speci®c protein occupancy, both in vivo and in vitro (see, for instance, McPherson et al., 1993; Steger and Workman, 1997; Tsukiyama et al., 1994) . Our DMS and DNase I footprinting data show that protection, hypersensitivity (to DNase I) or hyperreactivity (to DMS) can be detected in correspondence of the binding sites for the dierent factors (Figures 4 and  5 ). This result is in line with the need of de novo synthesis of AP1-binding transcription factors in the induction of uPA transcription (Lee et al., 1993; P Verde, personal communication) . Unexpectedly, in vivo footprinting with DMS and DNase I also shows that occupancy of the NF-kB site, located a few base pairs downstream from the enhancer, changes upon stimulation. Thus in vivo footprinting experiments expand the size of the uPA enhancer over that found by transfection experiments with a reporter gene in HepG2 cells (Novak et al., 1991; Verde et al., 1988) . This agrees with data in A549 cells showing that TPA induction of uPA gene transcription acts through NFkB (Geurrini et al., 1996) .
In unstimulated HepG2 cells, we ®nd no evidence for the presence of a single or of a few positioned nucleosome(s) or its presence at alternate positions. Indeed, the observed pattern of DNase I in vivo footprinting does not show either a single or overlapping *10 bp cleavage periodicity patterns ( Figure  5 ). This result is also supported by the in vivo footprinting data carried out with MNase ( Figure 6 ) and OP-Cu, which do not show the presence of nucleosome boundaries upstream or downstream of the enhancer and by the indirect end-labelling of Southern blots of MNase cleaved genomic DNA which does not show any regular cleavage in this region. However, our results also do not indicate a totally random distribution of nucleosomes in this region: the in vivo footprinting pattern we observe with MNase and OP-Cu in untreated cells is dierent from that of naked DNA, as it would be expected if nucleosomes were randomly distributed in the enhancer region. Therefore, the failure to detect positioned nucleosomes in the enhancer and surrounding sequences, as well as that to detect a totally random distribution suggests that a limited number of translational nucleosomal positions may be possible in this region. Their number, however, is too large to be clearly detected.
Our data also show that upon TPA induction and enhancer occupancy by trans-acting factors, despite an increase in the sensitivity to DNase I and accessibility to restriction nucleases, this region still maintains a substantial protection from cleavage. The indirect endlabelling experiments show a pattern of digestion compatible with a nucleosomal structure of the region Figure 9 Restriction enzyme accessibility of the enhancer reaches a maximum after a 1 h TPA treatment of HepG2 cells. Timecourse TPA stimulation of HepG2 cells was as described in Materials and methods, as well as the preparation of nuclei and digestion with BspHI. TaqI restriction of puri®ed DNA, fractionation on an agarose gel and transfer to a nylon membrane was as in Figure 8 . Labelled probe p5 (see Figure  1b ) was used to analyse the Southern blot. Autoradiogram of the indirectly end-labelled Southern blot shows that the BspHI band increases up to 1 h and remains constant thereafter, while the TaqI genomic band decreases only marginally (Figure 7) and also the time course of onset and reversal of hypersensitivity of the enhancer suggest that large remodelling events are unlikely to take place (Figure 3 ). Thus we speculate that, upon TPA stimulation, more subtle changes occur, if any, at the level of individual nucleosomes in the array.
In conclusion, we have analysed the state of the uPA enhancer upon TPA stimulation of HepG2 cells. Our data show that the underlying overall nucleosomal structure of this region, which does not contain uniquely positioned nucleosomes, is maintained also upon induction of transcription. TPA stimulation causes an increase in nucleases sensitivity and accessibility of the enhancer region. Such an increase is accompanied by occupancy of the various elements of the enhancer. Unexpectedly, also of the nearby NFkB site is occupied; this calls for a reevaluation of the role of this factor in the control of the transcriptional regulation of the uPA gene. These results overall support the data previously obtained in vitro and by transient transfections, which involve the enhancer region in the induction of uPA gene transcription and show that in vivo the persistence of a nucleosomal structure of this element does not interfere with its function.
Materials and methods

Cell culture
HepG2 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM; Gibco Diagnostics) containing 10% (v/v) foetal calf serum, 0.2 mg/ml streptomycin and 50 U/ml penicillin. In experiments requiring phorbol esters stimulation, HepG2 cells were starved for 2 h and treated for 15 min to 3 h with 100 ng/ml TPA, as described in the Figures. In the immuno¯uorescence experiment, control cells were either not starved or starved for 2 or 5 h. In stimulation/withdrawal experiment, a 3 h stimulation of HepG2 cells was followed by washing the cells three times with DMEM and incubating them with fresh medium for 3 h before isolation of the nuclei.
RNA puri®cation and Northern blotting
Total RNA was extracted from cells using guanidinium isothiocyanate followed by repeated phenol: chloroform: isoamyl alcohol extractions and isopropranol precipitations (Ausubel et al., 1994) . It was then fractionated, transferred to a Hybond N + (Amersham) membrane and probed with a human uPA cDNA (Verde et al., 1984) labelled with a-32 PdCTP using the Rediprime kit (Amersham) as described by the manufacturer.
Isolation of nuclei, DNase I and MNase digestion
Exponentially growing cells (1 ± 5610 8 cells) were harvested, washed twice in ice-cold phosphate-buered saline (PBS) and pelleted at 750 g for 5 min at 48C. Cells were re-suspended in buer HB (15 mM Tris-HCl pH 8; 60 mM KCl; 15 mM NaCl; 320 mM sucrose; 0.05 mg/ml dithiotreitol (DTT)), containing 0.5 mM spermine and 0.15 mM spermidine, and kept on ice for 3 min. NP40 was added to 0.1% (v/v) ®nal concentration and the cells lysed by inversion of the tube. Lysed cells were diluted ice-cold HB buer with spermine and spermidine and the nuclei pelleted at 1500 g for 5 min at 48C. They were then re-suspended in ice-cold HB buer containing spermine and spermidine and centrifuged as above for 10 min. Isolated nuclei were washed once more in HB buer without spermidine and spermidine and centrifuged as above. For DNase I and MNase digestions, nuclei from one 15 cm diameter Petri dish were resuspended in a ®nal volume of 2 ml of HB buer, without spermine and spermidine, containing 3 mM MgCl 2 (DNase I) or 2 mM CaCl 2 (MNase). DNase I (Boehringer Mannheim) was added at the concentrations indicated in the legends to the ®gures and the digestion proceeded for 10 min at 378C. MNase was added at 5 U/ml and digestion proceeded for the times indicated in the ®gures at 378C. The reactions were stopped by the addition of 1/5 of the volume of 2.5% (w/v) sodium lauryl sarcosine and 100 mM EDTA pH 8 and the tubes put on ice. RNase A (Boehringer Mannheim) was added at a ®nal concentration of 50 mg/ml for 1 h at 378C, followed by the addition of SDS and proteinase K (®nal concentrations 0.5% (w/v) and 0.5 mg/ml, respectively) overnight at 378C. Samples were then extracted three times with buered phenol; three times with phenol:chloroform:isoamyl-alcohol (25 : 24 : 1) and three times with chloroform:isoamyl alcohol (24 : 1), precipitated and re-suspended in TE. The extent of digestion was determined by electrophoresis of an aliquot of DNA on a 1% (w/v) agarose gel in 16TAE buer (Ausubel et al., 1994) .
Non-enzymatic cleavage of isolated nuclei
Copper phenantroline (OP-Cu) of isolated nuclei were as described (Quivy and Becker, 1997) .
Restriction enzyme digestion of puri®ed nuclei
Nuclei from exponentially growing, TPA-treated and control HepG2 cells (2 ± 4610 7 cells) were isolated as above and the ®nal resuspension was at 10 8 nuclei/ml in buer B (10 mM Tris-HCl pH 7.9, 10 mM MgCl 2 , 50 mM NaCl, 1 mM DTT, 100 mg/ml BSA, 0.1 mM PMSF). 10 7 nuclei were digested for 30 min at 378C with 40 U of each restriction enzyme in a total volume of 100 ml. Nuclei used in Figure 9 were digested for 60 min with 100 U of BspHI (Boehringer Mannheim) in 1 ml. Digestions were stopped by the addition of proteinase K buer (200 mM NaCl, 100 mM Tris-HCl pH 7.5, 2 mM EDTA and 1% (w/v) SDS). DNA puri®cation, transfer to nylon membrane and probing were as previously described.
Southern blotting
Puri®ed DNA from isolated nuclei of unstimulated or TPAstimulated HepG2 cells digested with DNase I or restriction enzymes was further restricted overnight with the appropriate enzymes in a volume of 500 ml, precipitated and electrophoresed on a 1% (w/v) agarose gel in 0.56TBE (Ausubel et al., 1994 ) at 1.5 V/cm. Agarose gels were soaked twice for 30 min in 0.6 M NaCl, 0.4 M NaOH, twice for 30 min in 1.5 M NaCl, 0.5 M Tris-HCl pH 7.2, 1 mM EDTA. DNA was transferred to Hybond-N + membrane (Amersham), probed and washed as described by the manufacturer. The appropriate genomic fragments used as probes were labelled as above (see RNA puri®cation and Northern blotting).
Probes
Probes are schematically described in Figure 1b . Probe p2 is a 338 bp PCR fragment; probe p5 is a 510 bp EcoRI-BstXI restriction fragment from plasmid pBSK-822 (obtained by cloning the whole insert of puPA-CAT-822 (Verde et al., 1988) in pBluescript-Stratagene). Probe p14 is a 408 bp fragment obtained by AspI digestion of the region from 72000 to 71592.
In vivo footprinting by linker tag selection ligation-mediated PCR (LTS LM-PCR)
Approximately 1 ± 2610 7 TPA-stimulated or unstimulated HepG2 cells were treated with DMS and processed to obtain puri®ed DNA as described (Ausubel et al., 1994) . Chemical sequencing as described (Ausubel et al., 1994) was performed to obtain the`G' pattern. For DNase I and MNase digestions, approximately 2610 7 isolated nuclei were cleaved with 0.5 U/ml DNase I at 378C for 10 min in the presence of 3 mM MgCl 2 or with 3 U/ml MNase at 378C for 2 min in the presence of 2 mM CaCl 2 . The reactions were stopped and the DNA puri®ed as described above. Naked DNA (120 mg) was treated with 0.1 U/ml of DNase I for 5 min or with 0.1 U/ml MNase for 2 min at 378C. MNase-treated DNA (15 mg) was further phosphorylated prior to linker tag-selection ligationmediated polymerase chain reaction (LTS LM ± PCR) analysis with 20 U of phage T4 polynucleotide kinase (New England Biolabs), supplemented with 200 mM ATP for 60 min at 378C and DNA was puri®ed as above.
LTS LM ± PCR reactions were carried out with the protocol outlined by (Quivy and Becker, 1996) with the following modi®cations: 1 mg of puri®ed DNA from dimethyl sulphate-(DMS) treated cells and 4 mg of puri®ed DNA from DNase I-or MNase-digested nuclei were used. The denaturation step was carried out at 708C for 5 min, annealing with primers P1 (5'-GTGCACAAAGATTTCA-GAG-3') or P4 (5'-TATAGGCTTCAGAGCCAAC-3') was performed at 508C or 528C, respectively. First strand extension was carried out at 768C for 10 min. Biotinylated, annealed oligonucleotides (Quivy and Becker, 1996) were ligated to the ®rst strand extended products and the ligated oligonucleotides puri®ed as described (Quivy and Becker, 1996) . PCR reactions were carried out with three Units of Vent DNA polymerase (New England Biolabs) with 22 cycles (958C for 1 min, 578C for 2 min; 768C for 3 min, increasing the last step by 5 s at each cycle), following a denaturation step at 958C for 5 min. The reaction was ended by incubating the samples at 768C for further 10 min. Alternatively, the kit Expand Long Template PCR System (Boehringer Mannheim) was used following the manufacturer's instructions and buer 1. The oligonucleotides employed in this step were: P2 (5'-GATTAGCGCATGGATAAGGAAGTTC-3') or P5 (5'-CTCTAGAAGACT-GTGGTCAGTTTTG-3'). Binding of PCR products to streptavidin-coated paramagnetic beads (Dynal), template denaturation, following washes and resuspensions were as described (Quivy and Becker, 1996) . The ®nal extension, using 32 P-labelled oligonucleotides P3 (5'-TGGATAAGGAAGTTCTGTGAAGAGTTGAAG-3', annealing temperature 598C) or P6 (5'-GTGGTCAGTTTTGTTTGGATTT-GAGAACCC-3', annealing temperature 608C), as well as the following steps of the procedure were performed as described (Quivy and Becker, 1996) .
The samples were loaded on a 6% (w/v) polyacrylamide (19 : 1) denaturing gel, containing 7 M urea. The gels were dried and autoradiographed for the appropriate time with either Kodak X-OMAT or Amersham Hyper®lm MP.
Abbreviations uPA: urokinase-type plasminogen activator; DNase I: deoxyribonuclease I; TPA: 12-O-tetradecanoyl-phorbol-12-acetate; MNase: micrococcal nuclease; COM: cooperation mediator; uCOM: upstream COM; dCOM: downstream COM; DMEM: Dulbecco's modi®ed Eagle's medium; SDS: sodium dodecyl sulphate; PBS: phosphate buered saline; DTT: dithiotreitol; EDTA: ethylene diamino tetra acetic acid; BSA: bovine serum albumin; PMSF: phenyl methyl sulphonyl¯uoride; UV: ultraviolet; LTS LM-PCR: linker tag-selection ligation-mediated polymerase chain reaction; OP-Cu: 1, 10-phenantroline-copper; GAPDH: glyceraldehyde 3-phosphate dehydrogenase.
